LumiraDx Inc: LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

Now Available in Europe, parts of the Middle East, Asia, Latin America, and AfricaEarly customers include GP offices and other community-based healthcare settingsLatest figures, released as part of World

Related Keywords

Austria ,United States ,United Kingdom ,London ,City Of ,America ,Johannes Pachler ,David Walton ,Colleen Mcmillen ,Leupamed Medizintechnik Gmb ,Garry John ,Committee Of The Scientific Division ,Group For The Global Standardisation Of Hb ,Norwich University Hospital ,Lumiradx Limited Nasdaq ,Norwich Medical School ,Now Available ,Middle East ,Latin America ,World Diabetes Day ,Lumiradx Hba ,Lumiradx Platform ,Chief Commercial Officer ,Consultant Clinical Biochemist ,Scientific Division ,Global Standardisation ,Honorary Professor ,Managing Director ,Leupamed Medizintechnik Gmbh ,Lumiradx ,Ontinues ,Commercial ,Expansion ,Rapid ,Microfluidic ,Immunoassay ,Ba1c ,Pest ,